AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2014
Apr 28, 2014
33090_dirs_2014-04-28_d346f7ca-d9d3-4f18-888b-6ead8e182972.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-04-24
Reporting Person: Harrell David (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-24 | Common Stock | S | 552500 | $1.60 | Disposed | 2705625 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-24 | Stock Options | $1.00 | S | 55650 | Disposed | 2016-05-31 | Common Stock (55650) | Direct |
More from OptimizeRx Corp
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23